| 2002 |
EHD3 localizes to endocytic vesicles and microtubule-dependent membrane tubules, colocalizing with transferrin-containing recycling vesicles; the N-terminal domain is responsible for tubular localization. EHD1 and EHD3 interact via two-hybrid analysis and co-immunoprecipitation from cellular extracts, and coexpression results in colocalization in microtubule-dependent tubules. |
GFP-fusion localization, N-terminal domain swapping/deletion mutagenesis, yeast two-hybrid, co-immunoprecipitation |
Traffic |
Medium |
12121420
|
| 2005 |
EHD3 binds the Rab11-effector Rab11-FIP2 via EH domain–NPF motif interactions; this association is affected by nucleotide-binding status. Knockdown of EHD3 prevents delivery of internalized transferrin and early endosomal proteins to the endocytic recycling compartment (ERC), demonstrating a role for EHD3 in early endosome-to-ERC transport distinct from EHD1's role in ERC exit. |
Co-immunoprecipitation, siRNA knockdown, transferrin recycling assay, subcellular localization imaging |
Molecular biology of the cell |
High |
16251358
|
| 2007 |
Rab8a and Myosin Vb colocalize to a tubular network containing EHD1 and EHD3 (distinct from Rab11a-containing compartments), as demonstrated by live-cell FRET imaging and co-localization studies. |
Yeast two-hybrid, FRET, live-cell imaging, co-localization |
Molecular biology of the cell |
Medium |
17507647
|
| 2009 |
siRNA knockdown of EHD3 (or its interaction partner rabenosyn-5) redistributes sorting nexin 1 to enlarged early endosomes, disrupts Shiga toxin B subunit transport to the Golgi, fragments Golgi morphology, reduces AP-1 gamma-adaptin recruitment to the Golgi, misroutes mannose 6-phosphate receptor to peripheral endosomes, and traps cathepsin D at the Golgi — establishing EHD3 as a regulator of early-endosome-to-Golgi transport required for Golgi morphology and lysosomal biosynthetic trafficking. |
siRNA knockdown, immunofluorescence, Shiga toxin transport assay, VSV-G secretion assay, mannose 6-phosphate receptor trafficking assay |
Journal of cell science |
High |
19139087
|
| 2011 |
Mice doubly deficient for EHD3 and EHD4 develop thrombotic microangiopathy-like glomerular lesions with altered VEGFR2 expression and localization in glomerular endothelium and increased apoptosis, suggesting EHD3/EHD4-mediated endocytic recycling of VEGFR2 is essential for glomerular endothelial homeostasis. |
Ehd3−/− and Ehd3−/−;Ehd4−/− mouse models, histopathology, immunofluorescence, proteinuria measurement |
PloS one |
Medium |
21408024
|
| 2013 |
siRNA knockdown or doxycycline-inducible restoration of EHD3 in glioma cell lines shows EHD3 decreases cell growth and invasiveness, induces cell cycle arrest and apoptosis; promoter hypermethylation silences EHD3 expression and is reversible by 5-Azacytidine; xenograft experiments confirm in vivo tumor suppressive activity. |
siRNA knockdown, doxycycline-inducible overexpression, bisulfite sequencing, 5-Azacytidine demethylation, xenograft mouse model, cell cycle/apoptosis assays |
Carcinogenesis |
Medium |
24306026
|
| 2013 |
siRNA depletion of EHD3 in HeLa cells delays short-loop β3-integrin recycling from early endosomes back to the cell surface and impairs αvβ3-integrin-mediated cell adhesion. TIRF-based colocalization shows β3-integrin transits EHD3-positive endosomes near the cell surface, consistent with a rapid-recycling role. |
siRNA knockdown, live-cell TIRF microscopy, integrin recycling assay, cell adhesion assay |
Journal of cell science |
Medium |
23781025
|
| 2014 |
EHD3-deficient mouse hearts display bradycardia, conduction block, and blunted adrenergic response. EHD3-deficient myocytes have reduced membrane expression/localization of Na/Ca exchanger (NCX1) and L-type Ca channel Cav1.2, reduced corresponding membrane currents, increased sarcoplasmic reticulum Ca2+ and spark frequency, and reduced ankyrin-B expression/localization. Ankyrin-B co-immunoprecipitates with EHD3 and NCX1, placing EHD3 in an endosome-based trafficking pathway for these cardiac membrane proteins. |
Cardiac-specific EHD3 KO mouse, electrophysiology, patch-clamp, immunofluorescence/confocal microscopy, co-immunoprecipitation, Ca2+ spark imaging |
Circulation research |
High |
24759929
|
| 2012 |
EHD3 protein levels are consistently elevated in four different heart failure models (ischemic rat, pressure-overload mouse, pacing-induced canine, and failing human myocardium); NCX1 levels parallel EHD3 upregulation. EHD3 upregulation in heart failure is downstream of reactive oxygen species and angiotensin II signaling. |
Western blot across multiple HF models, ROS and angiotensin II pharmacological manipulation |
Journal of molecular and cellular cardiology |
Medium |
22406195
|
| 2015 |
EHD3 undergoes SUMO modification at lysines K315 and K511, both in vitro and in cells. SUMOylation is required for EHD3 localization to tubular ERC structures; non-SUMOylated EHD3 acts as a dominant negative for tubulation and delays transferrin recycling from the ERC to the cell surface. SUMOylation does not affect EHD3 dimerization. |
In vitro SUMOylation assay, site-directed mutagenesis of SUMO acceptor lysines, transferrin recycling assay, immunofluorescence |
PloS one |
High |
26226295
|
| 2015 |
EHD1 and EHD3, together with the Rab11–Rab8 cascade, localize to preciliary membranes and the ciliary pocket. EHD-dependent membrane tubulation is required to form ciliary vesicles from distal appendage vesicles (DAVs) at the mother centriole, a step necessary for basal body transformation, transition zone protein recruitment, and IFT20 recruitment before ciliary growth. SNAP29 (a SNARE and EHD1-binding protein) is also required for this DAV-to-ciliary-vesicle fusion step. |
siRNA knockdown, super-resolution and electron microscopy, live imaging, co-immunoprecipitation, rescue experiments |
Nature cell biology |
High |
25686250
|
| 2016 |
EHD3 stabilizes tubular recycling endosomes (TRE) rather than initiating their biogenesis; in a synchronized TRE regeneration assay (phospholipase D inhibitor washout), EHD3 depletion did not prevent TRE formation but shortened their persistence. The residues Asn-519/Glu-520 in EHD3's EH domain (vs. Ala-519/Asp-520 in EHD1) define the differential selectivity of these paralogs for NPF-containing binding partners, explaining distinct roles: EHD1 in vesiculation vs. EHD3 in tubule stabilization. |
siRNA knockdown, phospholipase D inhibitor washout assay, site-directed EH domain mutagenesis, co-localization imaging |
The Journal of biological chemistry |
High |
27189942
|
| 2016 |
EHD3 binds phosphatidic acid (PA) through its helical domain, as shown by in vitro liposome co-sedimentation. PA–EHD3 interaction induces liposomal tubulation in vitro. Inhibiting PA synthesis with diacylglycerol kinase inhibitor or lysophosphatidic acid acyltransferase inhibitor reduces EHD3-containing tubules and impairs early endosomal trafficking, establishing that PA cooperates with EHD3 to drive membrane tubulation. |
In vitro liposome co-sedimentation assay, pharmacological PA synthesis inhibition, immunofluorescence tubule counting |
Experimental cell research |
High |
26896729
|
| 2016 |
EHD3 accelerates EGFR degradation upon EGF stimulation by increasing EGFR ubiquitination and diverting EGFR trafficking from the recycling route to the degradative pathway. EHD3 reduces endosome-based MAPK and AKT signaling downstream of EGFR without affecting total pathway activity, demonstrating spatial regulation of EGFR signaling. |
Doxycycline-inducible EHD3 expression, EGFR ubiquitination assay, endosomal trafficking/recycling assays, immunofluorescence, western blot for pathway activation |
Oncotarget |
Medium |
27811356
|
| 2021 |
NR5A1 transcriptionally activates EHD3 by binding the conserved 'AGGTCA' sequence in the EHD3 promoter. EHD3 overexpression increases testosterone concentration; EHD3 knockdown decreases testosterone synthesis by reducing endocytosis in Leydig cells. Leydig-cell-specific NR5A1 knockout mice show reduced EHD3, clathrin, and serum testosterone levels. |
ChIP, dual luciferase reporter assay, siRNA knockdown, exosome tracing/endocytosis assay, conditional NR5A1 KO mouse (CRISPR/Cas9), ELISA |
Life sciences |
Medium |
33964295
|